Cas 1020105-12-7,1-Hydroxy-3-[4-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-benzenesulfonyl]-azepan-2-one

1020105-12-7

Post Buying Request

Basic information

Product Name: 1-Hydroxy-3-[4-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-benzenesulfonyl]-azepan-2-one
Synonyms: 1-Hydroxy-3-[4-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-benzenesulfonyl]-azepan-2-one
CAS NO:1020105-12-7
Molecular Formula:
Molecular Weight: 453.442
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-Hydroxy-3-[4-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-benzenesulfonyl]-azepan-2-one(CAS DataBase Reference)
NIST Chemistry Reference: 1-Hydroxy-3-[4-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-benzenesulfonyl]-azepan-2-one(1020105-12-7)
EPA Substance Registry System: 1-Hydroxy-3-[4-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-benzenesulfonyl]-azepan-2-one(1020105-12-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1020105-12-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1020105-12-7 Suppliers

Recommended suppliers

1020105-12-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1020105-12-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,0,1,0 and 5 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1020105-12:
(9*1)+(8*0)+(7*2)+(6*0)+(5*1)+(4*0)+(3*5)+(2*1)+(1*2)=47
47 % 10 = 7
So 1020105-12-7 is a valid CAS Registry Number.

1020105-12-7Upstream product

1020105-13-8 3-[4-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-benzenesulfonyl]-1-trityloxy-azepan-2-one

1020105-12-7Downstream Products

1020105-12-7Relevant academic research and scientific papers

HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS

-

Page/Page column 60, (2008/06/13)

This invention provides novel heterocyclic derived matrix metalloprotease inhibitors of the formula: and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing matrix metalloproteases. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1020105-12-7